In contrast, high levels of GSK3α in tumors were significantly positively associated with poor prognosis in colon cancer, whether in 74 tumors of different stages or in tumors of stage II, III, and IV alone (Fig. 1B), indicating that GSK3α is a key kinase in colon cancer. Here, GSK3A is linked to malignant colon neoplasm.